Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Andrea Piccin, Norberto Vezzali, Norbert Pescosta, Michael Steurer, Giovanni Palladini & Atto Billio. (2014) Ovarian hyperstimulation syndrome in systemic amyloidosis. Amyloid 21:1, pages 69-70.
Read now
Read now
Articles from other publishers (7)
Irina G. Rekhtina, Victoria A. Khyshova, Nadezhda I. Zozulya, Valentina N. Dvirnyk & Larisa P. Mendeleyeva. (2023) Hemostasis disorders in patients with systemic AL-amyloidosis. Terapevticheskii arkhiv 95:9, pages 746-750.
Crossref
Crossref
Florent Trescos, Nicolas Cazes, Anaïs Briquet, Benjamine Delcasso, Isabelle Graille, Romain Appay, Pierre-Mathieu Bonnet, Thanh Khoa Huynh & Jean-Baptiste Roseau. (2020) Pulmonary nodules associated with pulmonary embolism: A rare and misleading presentation of amyloidosis. Respiratory Medicine Case Reports 30, pages 101095.
Crossref
Crossref
Gina Patel, Parameswaran Hari, Aniko Szabo, Lisa Rein, Lisa Baumann Kreuziger, Saurabh Chhabra, Binod Dhakal & Anita D'Souza. (2019) Acquired factor X deficiency in light-chain (AL) amyloidosis is rare and associated with advanced disease. Hematology/Oncology and Stem Cell Therapy 12:1, pages 10-14.
Crossref
Crossref
Ombretta Annibali, Mariasanta Napolitano, Giuseppe Avvisati & Sergio Siragusa. (2018) Incidence of venous thromboembolism and use of anticoagulation in hematological malignancies: Critical review of the literature. Critical Reviews in Oncology/Hematology 124, pages 41-50.
Crossref
Crossref
O.K. Siddiqi & F.L. Ruberg. 2018. Encyclopedia of Cardiovascular Research and Medicine. Encyclopedia of Cardiovascular Research and Medicine
34
48
.
F.L. Ruberg. 2018. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Jacob P. Laubach, Javid J. Moslehi, Sanjeev A. Francis, Jesús F. San Miguel, Pieter Sonneveld, Robert Z. Orlowski, Philippe Moreau, Laura Rosiñol, Edward A. FaberJrJr, Peter Voorhees, Maria-Victoria Mateos, Loreta Marquez, Huaibao Feng, Avinash Desai, Helgi van de Velde, Jennifer Elliott, Hongliang Shi, Edward Dow, Nishith Jobanputra, Dixie-Lee Esseltine, Liviu Niculescu, Kenneth C. Anderson, Sagar Lonial & Paul G. Richardson. (2017) A retrospective analysis of 3954 patients in phase 2/3 trials of bortezomib for the treatment of multiple myeloma: towards providing a benchmark for the cardiac safety profile of proteasome inhibition in multiple myeloma. British Journal of Haematology 178:4, pages 547-560.
Crossref
Crossref